Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
about
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersDiagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-AnalysisTargeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28Ring-Shaped Microlanes and Chemical Barriers as a Platform for Probing Single-Cell MigrationNanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive systemInhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cellsThe synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinomaDose-dependent adverse effects of salinomycin on male reproductive organs and fertility in mice.Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells.Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.Maduramicin inhibits proliferation and induces apoptosis in myoblast cellsSalinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 CellsBreast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogsSalinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis.Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133(+) human colorectal cancer cells.Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-Κb P65 and Wnt/Β-Catenin in Vitro.Notch Signaling Coordinates Progenitor Cell-Mediated Biliary Regeneration Following Partial Hepatectomy.Oncogenic role of the Notch pathway in primary liver cancer.Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migrationSalinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.Salinomycin efficiency assessment in non-tumor (HB4a) and tumor (MCF-7) human breast cells.Apoptotic effects of salinomycin on human ovarian cancer cell line (OVCAR-3).Salinomycin radiosensitizes human nasopharyngeal carcinoma cell line CNE-2 to radiation.The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles.Salinomycin inhibits hepatocellular carcinoma cell invasion and migration through JNK/JunD pathway-mediated MMP9 expressionCasticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell lineGenistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT1.β-galactosyl-pyrrolidinyl diazeniumdiolate: an efficient tool to investigate nitric oxide functions on promoting cell death.Salinomycin: A new paradigm in cancer therapy.Salinomycin inhibits canine mammary carcinoma in vitro by targeting cancer stem cellsTargeting protein homeostasis with nelfinavir/salinomycin dual therapy effectively induces death of mTORC1 hyperactive cells.Biotransformation on the triterpenoid saponin of Ardisia gigantifolia by Aspergillus avenaceus AS 3.4454.Codelivery of salinomycin and chloroquine by liposomes enables synergistic antitumor activity in vitro.Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells.Influence of salinomycin treatment on division and movement of individual cancer cells cultured in normoxia or hypoxia evaluated with time-lapse digital holographic microscopy.Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer.The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin.
P2860
Q26739665-FC8FAF23-EBC5-4E70-96DE-F635A61C2975Q26863560-BCF52584-631D-4EA0-BF38-6AA738CC7662Q26991723-5DFD288F-CA0A-414A-B836-0C8A61744CB1Q27349210-7A24C370-D550-4250-B471-2EA257424D30Q28079367-ACD14BDC-379D-4CFC-A14C-DED8D2684729Q28534136-0E7330FB-BAE2-4345-AD1C-235CF43434A9Q28538669-DEB431BA-1BB4-4D98-AB87-0C69EE9F0B23Q28538702-A214F008-9879-4F83-91BC-E06EEAE8EADAQ34809302-39CA1D6B-D108-4EE7-A347-DD3ED0897F52Q35028765-F982AD7A-28FB-4040-A640-D04F94782DA2Q35159505-8AFF59C8-2350-4B22-A34A-3F64459E0AB3Q35410105-C7C55113-F17D-429C-ABE0-D3D397B5DC0CQ35532104-7E48B1B9-C7BF-439D-A6BC-8502D0913FE1Q35830305-9372E4FD-E5DE-4EB4-A5E3-3CD63B540AD2Q35932396-368E0806-FD22-4D1D-9481-5E0A53746B4CQ35983858-F6717741-ED72-42F5-AB3F-FE05605EB948Q36195433-B4B90C08-00F4-46C2-8046-BD994B1B6D91Q36226728-3F92FE10-8DDE-453B-A7CE-29D11750ACF1Q36661790-D3C72155-B42E-4F92-9160-72B67610F6A4Q37001697-87D1FFDC-EF4A-4D9F-A572-F38491CA917AQ37482536-0F7A8F91-A620-475E-BA0A-9909FFFCF720Q37539370-97C0CC4F-8D7C-42CD-98DE-6FC508607545Q38709612-292462D4-0B2D-45AD-812F-15CAE40C2BBEQ38789781-964B96E2-BDBA-4908-BA56-A7CC2EC144E5Q38827097-30CDC939-A21E-4214-A67D-43AF088787B0Q38849496-D38FE0C7-BC1F-4979-97AA-590AD23ECD12Q38857110-F9F24D89-55D6-4F6A-B0A5-2D1CA4E40B7EQ38927271-6FDAECE0-537A-4B64-8289-BB939DACBAC1Q38984431-6B5E71BB-B9E8-443C-81B6-801DA6B455B0Q39062127-B0C8EFBF-A375-48FB-AE02-94483FF9E4C0Q39134975-82687935-FAF3-4808-AA45-FDB97C047781Q39204541-C67D8CB5-5F18-481B-A02B-B5EB7E3060A4Q40977870-2BDA5725-6F7E-41BB-BAA2-8240F1EB0BBCQ41472073-29E049A3-79D7-4AAD-828C-A257AF70C05CQ41705570-85E705CB-D1A5-4F51-A619-BB0290AC5C3BQ41914702-B7759C6A-77CA-4517-95A4-D7F848D89D01Q46330183-3B24B157-C088-4E37-A29C-53EAA5887BD2Q47158789-B46B5903-1289-406C-9047-0B5F8635D713Q48213165-C8981524-31AA-4564-9E33-AAEA979F18ABQ55427695-536B0E6E-3779-4E98-ADD6-9CD4D45EA525
P2860
Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Salinomycin inhibits prolifera ...... ma cells in vitro and in vivo.
@ast
Salinomycin inhibits prolifera ...... ma cells in vitro and in vivo.
@en
Salinomycin inhibits prolifera ...... ma cells in vitro and in vivo.
@nl
type
label
Salinomycin inhibits prolifera ...... ma cells in vitro and in vivo.
@ast
Salinomycin inhibits prolifera ...... ma cells in vitro and in vivo.
@en
Salinomycin inhibits prolifera ...... ma cells in vitro and in vivo.
@nl
prefLabel
Salinomycin inhibits prolifera ...... ma cells in vitro and in vivo.
@ast
Salinomycin inhibits prolifera ...... ma cells in vitro and in vivo.
@en
Salinomycin inhibits prolifera ...... ma cells in vitro and in vivo.
@nl
P2093
P2860
P1433
P1476
Salinomycin inhibits prolifera ...... ma cells in vitro and in vivo.
@en
P2093
Chen-Feng Wang
Chuan-Yong Guo
Chun-Lei Lin
Ping Cheng
P2860
P304
P356
10.1371/JOURNAL.PONE.0050638
P407
P577
2012-12-20T00:00:00Z